NCT03563729View on ClinicalTrials.gov

Melanoma Metastasized to the Brain and Steroids

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

June 1, 2024

Study Completion Date

June 6, 2028

Conditions
Malignant Melanoma
Interventions
DRUG

Pembrolizumab Injection [Keytruda]

Alone

DRUG

Ipilimumab Injection [Yervoy]

In combination with nivolumab.

DRUG

Nivolumab Injection [Opdivo]

In combination with ipilimumab.

DRUG

Encorafenib

In combination with binimetinib

DRUG

Binimetinib

In combination with encorafenib

DRUG

Dabrafenib

In combination with dabrafenib

DRUG

Trametinib

In combination with trametinib

Trial Locations (3)

2730

RECRUITING

Herlev Universityhospital, Herlev

5000

NOT_YET_RECRUITING

Odense Universityhospital, Odense

8000

NOT_YET_RECRUITING

Aarhus Universityhospital, Aarhus

All Listed Sponsors
lead

Inge Marie Svane

OTHER